Spectrum of acute renal failure in the intensive care unit: The PICARD experience

被引:638
作者
Mehta, RL
Pascual, MT
Soroko, S
Savage, BR
Himmelfarb, J
Ikizler, TA
Paganini, EP
Chertow, GM
机构
[1] Univ Calif San Francisco, Dept Med Res, Div Nephrol, San Francisco, CA 94118 USA
[2] Univ Calif San Diego, Dept Med, Div Nephrol, San Diego, CA 92103 USA
[3] Maine Med Ctr, Dept Med, Div Nephrol, Portland, ME 04102 USA
[4] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN USA
[5] Cleveland Clin Fdn, Sect Extracorporeal Therapy, Dept Nephrol & Hypertens, Cleveland, OH 44195 USA
[6] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA USA
关键词
acute renal failure; cohort study; mortality; intensive care unit; severity of illness;
D O I
10.1111/j.1523-1755.2004.00927.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Acute renal failure (ARF) in the critically ill is associated with extremely high mortality rates. Understanding the changing spectrum of ARF will be necessary to facilitate quality improvement efforts and to design successful interventional trials. Methods. We conducted an observational cohort study of 618 patients with ARF in intensive care units at five academic medical centers in the United States. Participants were required to sign (or have a proxy sign) informed consent for data collection. A comprehensive data collection instrument captured more than 800 variables, most on a daily basis, throughout the course of ARF. Patient characteristics, dialysis status, and major outcomes were determined and stratified by clinical site. Results. The mean age was 59.5 years, 41% were women, and 20% were of minority race or ethnicity. There was extensive comorbidity; 30% had chronic kidney disease, 37% had coronary artery disease, 29% had diabetes mellitus, and 21% had chronic liver disease. Acute renal failure was accompanied by extrarenal organ system failure in most patients, even those who did not require dialysis. Three hundred and ninety-eight (64%) patients required dialysis. The in-hospital mortality rate was 37%, and the rate of mortality or nonrecovery of renal function was 50%. The median hospital length of stay was 25 days (26 days, excluding patients who died). Conclusion. There is a changing spectrum of ARF in the critically ill, characterized by a large burden of comorbid disease and extensive extrarenal complications, obligating the need for dialysis in the majority of patients. There is wide variation across institutions in patient characteristics and practice patterns. These differences highlight the need for additional multicenter observational and interventional studies in ARF.
引用
收藏
页码:1613 / 1621
页数:9
相关论文
共 33 条
  • [1] Anaritide in acute tubular necrosis
    Allgren, RL
    Marbury, TC
    Rahman, SN
    Weisberg, LS
    Fenves, AZ
    Lafayette, RA
    Sweet, RM
    Genter, FC
    Kurnik, BRC
    Conger, JD
    Sayegh, MH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (12) : 828 - 834
  • [2] Mortality and costs of acute renal failure associated with amphotericin B therapy
    Bates, DW
    Su, L
    Yu, DT
    Chertow, GM
    Seger, DL
    Gomes, DRJ
    Dasbach, EJ
    Platt, R
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) : 686 - 693
  • [3] Acute renal failure in the cardiac care unit: Etiologies, outcomes, and prognostic factors
    Behrend, T
    Miller, SB
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (01) : 238 - 243
  • [4] Acute renal failure in intensive care units - Causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study
    Brivet, FG
    Kleinknecht, DJ
    Loirat, P
    Landais, PJM
    Bedock, B
    Bleichner, G
    Richard, C
    Coste, F
    BrunBuisson, C
    Sicot, C
    Tenaillon, A
    Gajdos, P
    Blin, F
    Saulnier, F
    Agostini, MM
    Nicolas, F
    FeryLemonnier, E
    Staikowski, F
    Carlet, J
    Guivarch, G
    Fraisse, F
    Ricome, J
    Tempe, JD
    Mezzarobba, P
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (02) : 192 - 198
  • [5] Reasons for non-enrollment in a cohort study of ARF: The program to improve care in acute renal disease (PICARD) experience and implications for a clinical trials network
    Chertow, GM
    Pascual, MT
    Soroko, S
    Savage, BR
    Himmelfarb, J
    Ikizler, TA
    Paganini, EP
    Mehta, RL
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (03) : 507 - 512
  • [6] Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure?
    Chertow, GM
    Sayegh, MH
    Allgren, RL
    Lazarus, JM
    [J]. AMERICAN JOURNAL OF MEDICINE, 1996, 101 (01) : 49 - 53
  • [7] Chertow GM, 1998, J AM SOC NEPHROL, V9, P692
  • [8] PROGNOSTIC STRATIFICATION IN CRITICALLY ILL PATIENTS WITH ACUTE-RENAL-FAILURE REQUIRING DIALYSIS
    CHERTOW, GM
    CHRISTIANSEN, CL
    CLEARY, PD
    MUNRO, C
    LAZARUS, JM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (14) : 1505 - 1511
  • [9] Renal failure in the ICU: Comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes
    Clermont, G
    Acker, CG
    Angus, DC
    Sirio, CA
    Pinsky, MR
    Johnson, JP
    [J]. KIDNEY INTERNATIONAL, 2002, 62 (03) : 986 - 996
  • [10] Acute renal failure in the ICU:: risk factors and outcome evaluated by the SOFA score
    de Mendonça, A
    Vincent, JL
    Suter, PM
    Moreno, R
    Dearden, NM
    Antonelli, M
    Takala, J
    Sprung, C
    Cantraine, F
    [J]. INTENSIVE CARE MEDICINE, 2000, 26 (07) : 915 - 921